Xenon Pharmaceuticals Inc. diskutieren
Xenon Pharmaceuticals Inc.
WKN: A12ETN / Name: Xenon Pharms / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
38,20 €
-1,00 %
Gesundheit | Biotechnologie | Kanada
Eine bullische Anleger am RSI von 26,6 xene liest heute als Zeichen aussehen könnte , dass der jüngste schwere Verkauf läuft aus, und beginnen , für Einstiegspunkt Möglichkeiten auf der Kaufseite zu sehen
(Laufzeit überschritten)
melinda stimmt dem Sentiment von 'Buy' zu
melinda stimmt am 25.09.2017 dem Buy-Gesamtsentiment mit dem Kursziel 6.3$ zu.
melinda stimmt am 25.09.2017 dem Buy-Gesamtsentiment mit dem Kursziel 6.3$ zu.
(Vom Mitglied beendet)
(Vom Mitglied beendet)
SecteurRecherche biotechnologique et médicale Agenda 30/11 Présentation
Provides drug discovery and development services
Xenon Pharmaceuticals, Inc. is a biopharmaceutical company.
It engages in discovering and developing a pipeline of differentiated therapeutics.
It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.
The company has an integrated platform that includes in-house capabilities for human genetics, small molecule drug discovery and preclinical and clinical development.
Xenon Pharmaceuticals was founded by Simon Neil Pimstone, John J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals, Inc. is a biopharmaceutical company.
It engages in discovering and developing a pipeline of differentiated therapeutics.
It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.
The company has an integrated platform that includes in-house capabilities for human genetics, small molecule drug discovery and preclinical and clinical development.
Xenon Pharmaceuticals was founded by Simon Neil Pimstone, John J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Nombre d'employés : 81 personnes.
(Vom Mitglied beendet)
Buy mit Kursziel 18,0
Buy Xenon Pharmaceuticals Inc.
Buy Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Buy mit Kursziel 20,0
Sell Xenon Pharmaceuticals Inc.
Sell Xenon Pharmaceuticals Inc.
Neueste Beiträge
melinda in NEC Corp. diskutieren